Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Victoza
Victoza
Many patients keep weight off after stopping anti-obesity meds: study
Axios
Wed, 01/24/24 - 10:44 am
obesity
Novo Nordisk
Ozempic
Wegovy
Saxenda
Victoza
Novo Nordisk and Novartis put Victoza patent suit to bed, teeing up Sandoz copycat by 2024
Fierce Pharma
Wed, 03/23/22 - 10:38 am
Novo Nordisk
Novartis
Sandoz
Victoza
generics
patents
diabetes
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
Mon, 07/12/21 - 11:08 am
patents
patent cliff
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Revlimid
Pfizer
Eliquis
Regeneron
Eylea
JNJ
Stelara
Opdivo
GSK
Dolutegravir
Ibrance
Januvia
Eli Lilly
Trulicity
Novo Nordisk
Victoza
Amgen
Prolia
Xgeva
Novartis
Cosentyx
Takeda
Entyvio
Novo Nordisk scraps Type 1 diabetes drug after phase 2 trial
Fierce Biotech
Fri, 10/30/20 - 10:16 am
Novo Nordisk
NN9828
Victoza
clinical trials
type 1 diabetes
Mylan, seeking to market Victoza generic, convinces panel to start up patent review
Fierce Pharma
Wed, 06/24/20 - 11:18 pm
Mylan
patents
generics
Novo Nordisk
Victoza
diabetes
How a cocktail of existing drugs could regenerate insulin-producing cells in diabetes
Fierce Biotech
Thu, 02/13/20 - 10:44 am
diabetes
insulin
Mt Sinai
Novo Nordisk
Ozempic
Rybelsus
Victoza
Eli Lilly
Trulicity
AstraZeneca
Bydureon
Novo Nordisk’s quiet entry into the year of Alzheimer’s
EP Vantage
Mon, 01/20/20 - 10:19 pm
Novo Nordisk
Victoza
Alzheimer's disease
How Big Can This $8 Billion-Plus Diabetes Drug Class Get?
Motley Fool
Fri, 09/27/19 - 09:10 am
diabetes
Eli Lilly
Merck
Novo Nordisk
GSK
Byetta
Victoza
Bydureon
Ozempic
Tanzeum
Trulicity
Rybelsus
EASD: Novo's Ozempic tops Victoza, J&J's Invokana in double head-to-head win
Fierce Pharma
Tue, 09/17/19 - 03:41 pm
Novo Nordisk
Ozempic
JNJ
Invokana
Victoza
diabetes
EASD
Novo Nordisk and Mylan Battle Over Generic Versions of Victoza
BioSpace
Thu, 08/22/19 - 05:01 pm
Novo Nordisk
Mylan
generics
Victoza
diabetes
Novo Nordisk’s Victoza gets FDA okay for pediatric use
Pharmaforum
Tue, 06/18/19 - 10:10 am
Novo Nordisk
Victoza
type 2 diabetes
pediatric
Novo seeks Victoza label expansion with fresh pediatric trial results
Biopharma Dive
Mon, 04/29/19 - 09:33 pm
Novo Nordisk
type 2 diabetes
pediatrics
Victoza
Novo Nordisk settles US patent litigation case on Victoza (liraglutide) with Teva
Pharmaceutical Business Review
Wed, 03/20/19 - 12:16 pm
Novo Nordisk
Teva Pharmaceutical
patents
Victoza
diabetes
Novo's Victoza won't face Teva copies until 2023. Can semaglutide fill the gap by then?
Fierce Pharma
Mon, 03/18/19 - 05:05 pm
Novo Nordisk
diabetes
Teva Pharmaceutical
Victoza
semaglutide
Repurposing a GLP-1 diabetes drug to slow Parkinson’s disease
Fierce Biotech
Tue, 07/24/18 - 10:32 am
diabetes
Parkinson's Disease
GLP-1 agonist
AstraZeneca
Byetta
Bydureon
Novo Nordisk
Victoza
Ozempic
Eli Lilly
Trulicity
Peptron
ADA: Lilly's Trulicity bests Novo's Victoza, AZ's Bydureon in real-world study
Fierce Pharma
Mon, 06/25/18 - 09:07 pm
Eli Lilly
Trulicity
diabetes
Novo Nordisk
Victoza
AstraZeneca
Bydureon
ADA
Novo Nordisk's oral semaglutide impresses analysts against Victoza, Januvia
Fierce Pharma
Thu, 06/21/18 - 10:58 pm
Novo Nordisk
diabetes
semaglutide
Victoza
Merck
Januvia
GLP-1 Drug Class May Continue to Drive Growth for Novo Nordisk
Market Realist
Mon, 03/5/18 - 09:24 am
Novo Nordisk
GLP-1 agonist
diabetes
Victoza
NovoNordisk’s CSO openly addresses state of pharma sector
GoinPharma
Fri, 12/1/17 - 11:41 am
Novo Nordisk
Victoza
NASH
PCSK9 inhibitors
Humira back on top of TV spending list for October, ahead of Lyrica and Victoza
Fierce Pharma
Mon, 11/6/17 - 10:12 am
Humira
Lyrica
Victoza
AbbVie
Pfizer
Novo Nordisk
television ads
DTC ads
Pages
1
2
3
4
5
6
next ›
last »